Skip to Main Content

Author Details

Robert A Cornell
University of Iowa
1994
66
35
PMIDPaper TitleJournal TitlePublished Year
36493769Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes.Am J Hum Genet2023
36493769Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes.Am J Hum Genet2023
37161310A Variant in the <i>IRF6</i> Promoter Associated with the Risk for Orofacial Clefting.J Dent Res2023
37161310A Variant in the <i>IRF6</i> Promoter Associated with the Risk for Orofacial Clefting.J Dent Res2023
34403568Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish.Acta Physiol (Oxf)2022
35904815Hypersensitivity of Zebrafish htr2b Mutant Embryos to Sertraline Indicates a Role for Serotonin Signaling in Cardiac Development.J Cardiovasc Pharmacol2022
35580127TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes.PLoS Genet2022
34986152Motility phenotype in a zebrafish vmat2 mutant.PLoS One2022
34403568Vesicular monoamine transporter 2 (SLC18A2) regulates monoamine turnover and brain development in zebrafish.Acta Physiol (Oxf)2022
34913119Generating Zebrafish RNA-Less Mutant Alleles by Deleting Gene Promoters with CRISPR/Cas9.Methods Mol Biol2022
35580127TFAP2 paralogs facilitate chromatin access for MITF at pigmentation and cell proliferation genes.PLoS Genet2022
35904815Hypersensitivity of Zebrafish htr2b Mutant Embryos to Sertraline Indicates a Role for Serotonin Signaling in Cardiac Development.J Cardiovasc Pharmacol2022
34913119Generating Zebrafish RNA-Less Mutant Alleles by Deleting Gene Promoters with CRISPR/Cas9.Methods Mol Biol2022
34986152Motility phenotype in a zebrafish vmat2 mutant.PLoS One2022
33438577MITF reprograms the extracellular matrix and focal adhesion in melanoma.Elife2021
34252731Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.Toxicol In Vitro2021
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
33438577MITF reprograms the extracellular matrix and focal adhesion in melanoma.Elife2021
34664432The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.Epilepsia Open2021
34529939Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.Dev Cell2021
34529939Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation.Dev Cell2021
34664432The opioid antagonist naltrexone decreases seizure-like activity in genetic and chemically induced epilepsy models.Epilepsia Open2021
34252731Stable expression of the human dopamine transporter in N27 cells as an in vitro model for dopamine cell trafficking and metabolism.Toxicol In Vitro2021
34140478BRN2 is a non-canonical melanoma tumor-suppressor.Nat Commun2021
32582293Functional Characterization of a Novel IRF6 Frameshift Mutation From a Van Der Woude Syndrome Family.Front Genet2020
32031521Analysis of zebrafish periderm enhancers facilitates identification of a regulatory variant near human <i>KRT8/18</i>.Elife2020
32758111Genome-wide Analyses Identify a Novel Risk Locus for Nonsyndromic Cleft Palate.J Dent Res2020
32582293Functional Characterization of a Novel IRF6 Frameshift Mutation From a Van Der Woude Syndrome Family.Front Genet2020
32031521Analysis of zebrafish periderm enhancers facilitates identification of a regulatory variant near human <i>KRT8/18</i>.Elife2020
32758111Genome-wide Analyses Identify a Novel Risk Locus for Nonsyndromic Cleft Palate.J Dent Res2020
30452639Genomic analyses in African populations identify novel risk loci for cleft palate.Hum Mol Genet2019
30452639Genomic analyses in African populations identify novel risk loci for cleft palate.Hum Mol Genet2019
31215115Mutations in GDF11 and the extracellular antagonist, Follistatin, as a likely cause of Mendelian forms of orofacial clefting in humans.Hum Mutat2019
31215115Mutations in GDF11 and the extracellular antagonist, Follistatin, as a likely cause of Mendelian forms of orofacial clefting in humans.Hum Mutat2019
28886269Loss-of-Function GRHL3 Variants Detected in African Patients with Isolated Cleft Palate.J Dent Res2018
28886269Loss-of-Function GRHL3 Variants Detected in African Patients with Isolated Cleft Palate.J Dent Res2018
29927928Craniofacial genetics: Where have we been and where are we going?PLoS Genet2018
29162626Identification of Isthmin 1 as a Novel Clefting and Craniofacial Patterning Gene in Humans.Genetics2018
30847362Drug repositioning in epilepsy reveals novel antiseizure candidates.Ann Clin Transl Neurol2018
29927928Craniofacial genetics: Where have we been and where are we going?PLoS Genet2018
30847362Drug repositioning in epilepsy reveals novel antiseizure candidates.Ann Clin Transl Neurol2018
29162626Identification of Isthmin 1 as a Novel Clefting and Craniofacial Patterning Gene in Humans.Genetics2018
28029220Exome sequencing provides additional evidence for the involvement of ARHGAP29 in Mendelian orofacial clefting and extends the phenotypic spectrum to isolated cleft palate.Birth Defects Res2017
28795449Zebrafish models of orofacial clefts.Dev Dyn2017
29044856Zebrafish as models for developmental disease &amp; repair.Dev Dyn2017
28739660A Gene Implicated in Activation of Retinoic Acid Receptor Targets Is a Novel Renal Agenesis Gene in Humans.Genetics2017
28649789Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.Pigment Cell Melanoma Res2017
28287101Identification of common non-coding variants at 1p22 that are functional for non-syndromic orofacial clefting.Nat Commun2017
28249010TFAP2 paralogs regulate melanocyte differentiation in parallel with MITF.PLoS Genet2017
28029220Exome sequencing provides additional evidence for the involvement of ARHGAP29 in Mendelian orofacial clefting and extends the phenotypic spectrum to isolated cleft palate.Birth Defects Res2017
  • 1 - 50 of 132

Recommended Authors

Emily Sempou
Yale University School of Medicine
Career Start Year 2009
Number of shared co-authors 0
Malcolm Fisher
Cincinnati Children's Hospital Medical Center
Career Start Year 2002
Number of shared co-authors 1
Jon D Larson
NCI-Designated Cancer Center, Sanford Burnham Prebys Medical Discovery Institute
Career Start Year 2000
Number of shared co-authors 0
Takae Kiyama
University of Texas Health Science Center at Houston Medical School
Career Start Year 1998
Number of shared co-authors 1
John B Wallingford
University of Texas
Career Start Year 1997
Number of shared co-authors 0
Rebecca D Burdine
Princeton University
Career Start Year 1997
Number of shared co-authors 1
Su Guo
University of California san francisco
Career Start Year 1995
Number of shared co-authors 0
Seth Blackshaw
Johns Hopkins University School of Medicine.
Career Start Year 1994
Number of shared co-authors 0
Tiffany A Cook
Wayne State University School of Medicine
Career Start Year 1994
Number of shared co-authors 0
Semil P Choksi
University of California, USA Cardiovascular Research Institute san francisco
Career Start Year 1994
Number of shared co-authors 0
Jeffrey M Trimarchi
Inc., Lehigh University
Career Start Year 1994
Number of shared co-authors 0
Ferenc M??ller
University of Birmingham
Career Start Year 1992
Number of shared co-authors 0
Mustafa K Khokha
Yale University School of Medicine
Career Start Year 1992
Number of shared co-authors 2
Andrew K Groves
Baylor College of Medicine
Career Start Year 1991
Number of shared co-authors 1
Aaron M Zorn
Cincinnati Children's Hospital Medical Center
Career Start Year 1991
Number of shared co-authors 1
Alan Rawls
Arizona State University
Career Start Year 1989
Number of shared co-authors 0
Juan Carlos Izpisua Belmonte
Inc., Salk Institute for Biological Studies
Career Start Year 1989
Number of shared co-authors 0
Ali H Brivanlou
the Rockefeller University
Career Start Year 1989
Number of shared co-authors 0
Paris Ataliotis
Molecular and Clinical Sciences Research Institute, University of London
Career Start Year 1989
Number of shared co-authors 0
Fran??ois Guillemot
the Francis Crick Institute
Career Start Year 1986
Number of shared co-authors 1
Peter D Vize
University of Calgary
Career Start Year 1986
Number of shared co-authors 1
Ethan Bier
University of California
Career Start Year 1985
Number of shared co-authors 0
James A Coffman
University of Maine
Career Start Year 1984
Number of shared co-authors 1
Christopher V E Wright
Vanderbilt University
Career Start Year 1983
Number of shared co-authors 0
Clifford J Tabin
Harvard Medical School
Career Start Year 1982
Number of shared co-authors 1
Richard L Maas
Brigham and Women's Hospital, Harvard Medical School
Career Start Year 1980
Number of shared co-authors 3
Claude Desplan
New York University
Career Start Year 1977
Number of shared co-authors 0
Monte Westerfield
Institute of Neuroscience, University of Oregon
Career Start Year 1975
Number of shared co-authors 3
William H Klein
Columbia University
Career Start Year 1972
Number of shared co-authors 1
Mario R Capecchi
University of Utah School of Medicine
Career Start Year 1965
Number of shared co-authors 3

Collaborators

Eric Van Otterloo
College of Dentistry & Dental Clinics, University of Iowa
Co-authored papers 10
Mary L Marazita
Center for Craniofacial and Dental Genetics, University of Pittsburgh
Co-authored papers 6
Judith S Eisen
Institute of Neuroscience, University of Oregon
Co-authored papers 5
Lionel Larue
Institut Curie, PSL Research University, INSERM U1021
Co-authored papers 4
Eir??kur Steingr??msson
BioMedical Center, University of Iceland
Co-authored papers 4
Val??rie Petit
INSERM U1021, Institut Curie, PSL Research University, Campus Universitaire
Co-authored papers 3
Adebowale Adeyemo
Center for Research on Genomics and Global Health, National Institutes of Health
Co-authored papers 3
Stacie K Loftus
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Axel Visel
Co-authored papers 2
Tony Roscioli
Prince of Wales Hospital
Co-authored papers 2
Mitchell P Levesque
University Hospital Zurich
Co-authored papers 2
William J Pavan
National Human Genome Research Institute, National Institutes of Health
Co-authored papers 2
Michael S Hildebrand
Co-authored papers 2
Margret H Ogmundsdottir
Biomedical Center, University of Iceland
Co-authored papers 2
Erna Magn??sd??ttir
University of Iceland
Co-authored papers 2
Cathy C Laurie
Co-authored papers 2
Deepti Jain
Co-authored papers 2
Richard A Sturm
Frazer Institute, The University of Queensland, Dermatology Research Centre
Co-authored papers 1
Itai Yanai
Institute for Systems Genetics NYU Grossman School of Medicine
Co-authored papers 1
Robert Siddaway
Hospital for Sick Children
Co-authored papers 1
Andrew S McCallion
Johns Hopkins University School of Medicine
Co-authored papers 1
Karen L Mohlke
Co-authored papers 1
Santhosh Girirajan
The Huck Institutes of Life Sciences, University Park, Pennsylvania State University
Co-authored papers 1
Ingo Ruczinski
Co-authored papers 1
Kimberly F Doheny
Center for Inherited Disease Research, Johns Hopkins School of Medicine
Co-authored papers 1
Deborah A Nickerson
University of Washington
Co-authored papers 1
Thomas Strub
Co-authored papers 1
Colin R Goding
Ludwig Institute for Cancer Research, University of Oxford
Co-authored papers 1
Charles N Rotimi
Center for Research on Genomics and Global Health, National Institutes of Health
Co-authored papers 1
Alexander M Metcalf
Queensland Institute of Medical Research
Co-authored papers 1
Release 1.2